Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Pediatric Hematology/Oncology
•
Neurology
•
Child Neurology
•
Neurogenetics
At what point should surgical intervention be considered for vestibular schwannomas or other tumors in pediatric NF2 patients?
Related Questions
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
How long would you stop standard GBM radiotherapy if the patient had a fall with minor head trauma?
How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?
What factors do you consider when determining eligibility for hematopoietic stem cell therapies for metachromatic leukodystrophy?
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
When do you consider cannabidiol for treatment of epilepsy?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
For a patient with large volume glioblastoma, what do you do if they are found to have a subdural infection in the middle of chemoRT requiring repeat surgery?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
What factors do you take into account when deciding the length of adjuvant temozolamide in GBM?
